Clinical Trial Update: Study Evaluating Prevenar in High-Risk Children

View source ↗

Summary

This clinical trial update notes that the study evaluating the Prevenar pneumococcal vaccine in high-risk children has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Pneumococcal Disease | Status: COMPLETED